NEW YORK (GenomeWeb News) — GenTel BioSciences today said it has completed a round of financing worth $2 million.
GenTel CEO Alex Vodenlich said in a statement that the funding was “critical” and that the company had raised $500,000 more than initially anticipated.
 
The company did not discuss how it would spend the cash.
 
The investment was led by NEW Capital Fund and Wisconsin Investment Partners, both Wisconsin-based investors with an interest in the life sciences industry.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.